Rubicon OrganicsROMJF -2.45%48 PS Ratio is 0.50 as of Jun. 27, 2026, which is 57% below its 10-year median of 1.15. GuruFocus rates ROMJF with a GF Score™ of 48/100 and a GF Value™ of $0.38 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 953 Drug Manufacturers companies, Rubicon Organics ranks better than 87.51% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Rubicon Organics's share price is $0.315.
Rubicon Organics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.63. Hence, Rubicon Organics's PS Ratio for today is 0.50.
Good Sign:
Rubicon Organics Inc stock PS Ratio (=0.51) is close to 1-year low of 0.47.
The historical rank and industry rank for Rubicon Organics's PS Ratio or its related term are showing as below:
ROMJF'
s PS Ratio Range Over the Past 10 Years
Min: 0.4 Med: 1.15 Max: 250
Current: 0.51
During the past 10 years, Rubicon Organics's highest PS Ratio was 250.00. The lowest was 0.40. And the median was 1.15.
ROMJF's PS Ratio is ranked better than 87.51% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.2
vs ROMJF: 0.51
Rubicon Organics Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Rubicon Organics was -1.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 12.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 30.60% per year.
During the past 10 years, Rubicon Organics's highest 3-Year average Revenue per Share Growth Rate was 107.40% per year. The lowest was 12.00% per year. And the median was 37.80% per year.
Back to Basics: PS Ratio
Rubicon Organics (OTCPK:ROMJF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Rubicon Organics PS Ratio Related Terms
Rubicon Organics PS Ratio Historical Data
* Premium members only.
The historical data trend for Rubicon Organics's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Organics PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's PS Ratio distribution charts can be found below:
* The bar in red indicates where Rubicon Organics's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Rubicon Organics's Share Price of today is $0.315. Rubicon Organics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.63.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Rubicon Organics (ROMJF) has a PS Ratio of 0.50 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Rubicon Organics and its competitors. This is 57% below median its historical median of 1.15. Over the past decade, Rubicon Organics' PS Ratio has ranged from 0.40 to 250.00. According to the industry distribution chart, Rubicon Organics ranks #119 out of 953 companies in the Drug Manufacturers industry, placing it in the top 12.5%.
Is Rubicon Organics' PS Ratio too high?
Rubicon Organics' current PS Ratio of 0.50 is 57% below median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 250.00. The Drug Manufacturers industry median PS Ratio is 2.20. Rubicon Organics' value of 0.50 is 77.3% below this industry median. Based on the distribution chart, Rubicon Organics ranks #119 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Rubicon Organics has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rubicon Organics' PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Rubicon Organics ranks #119 out of 953 companies for PS Ratio. This places Rubicon Organics in the top 13% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.20. Rubicon Organics' value of 0.50 is 77.3% below this benchmark. Historically, Rubicon Organics' own PS Ratio has ranged from 0.40 to 250.00 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 2.20, Rubicon Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.20, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rubicon Organics's current PS Ratio of 0.50 is 77.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Rubicon Organics and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Organics's current PS Ratio is 0.50, which is 57% below median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Organics stock overvalued right now?
Based on GuruFocus' analysis, Rubicon Organics (ROMJF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.38, compared to a current price of $0.32 — trading 17.1% below its estimated fair value. The current PS Ratio is 0.50, which is 57% below median its 10-year median of 1.15 and 77.3% below the Drug Manufacturers industry median of 2.20. Rubicon Organics' overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Rubicon Organics (ROMJF), the current PS Ratio is 0.50 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rubicon Organics (ROMJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rubicon Organics stock appears to be undervalued.
The current stock price of $0.32 is trading 17.1% below its estimated GF Value™ of $0.38.
GuruFocus considers Rubicon Organics to be Modestly Undervalued.
Key valuation signals for ROMJF:
PS Ratio: 0.50 (57% below median its 10-year median of 1.15)
GF Value™: $0.38 vs. price of $0.32 (17.1% below fair value)
Industry Position: 77.3% below the Drug Manufacturers median (#119 of 953)
No single metric tells the full story. See the ROMJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rubicon Organics Inc is engaged in the production and sale of cannabis in Canada. The company produces and processes organic cannabis at its wholly owned, federally licensed 125,000 square foot facility in Delta, British Columbia which it sells under its wholly owned brands and certain wholesale channels. Its brands include Simply Bare, 1964 Supply Co, Wildflower, and Homestead Cannabis Supply. It operates in a single reportable segment, being the production and sale of cannabis in Canada.
48GF Score
Get the complete analysis for ROMJF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROMJF has been successfully added to your 
